Your browser doesn't support javascript.
loading
Dehydrocostus Lactone Reduced Malignancy of HepG2 Human Hepatocellular Carcinoma Cells via Down-Regulation of the PI3K/AKT Signaling Pathway.
Gu, W; Zhao, H; Yuan, H; Zhao, S.
Afiliação
  • Gu W; Department of Intervention Therapy, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
  • Zhao H; Department of Intervention Therapy, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
  • Yuan H; Department of Intervention Therapy, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
  • Zhao S; Department of Intervention Therapy, Affiliated Hospital of Nantong University, Nantong, Jiangsu, China. zhaosuming11211@163.com.
Bull Exp Biol Med ; 174(3): 360-364, 2023 Jan.
Article em En | MEDLINE | ID: mdl-36723745
ABSTRACT
We studied the effect of dehydrocostus lactone (DHL) on the biological characteristics of HepG2 human hepatocellular carcinoma cells. The inhibition of cell viability by different concentrations of DHL (10, 20, 40, 80, and 160 µmol/liter) was measured using MTT test. As the determined half-maximum inhibitory concentration (IC50) was 20.33 µmol/liter, DHL in a concentration of 20 µmol/liter was used in further experiments. Cell proliferation, migration, invasion ability, and apoptosis were assessed by Ki-67 immunofluorescence, Transwell assay, and TUNEL analysis. The level of p-AKT protein was determined by Western blotting. DHL significantly inhibited the viability, proliferation, migration, and invasion of HepG2 cells in comparison with the control group, and induced cells apoptosis. DHL down-regulated the expression of p-AKT protein in the HepG2 cells in comparison with the control group. PI3K/AKT signaling pathway activator 740Y-P could block the above-mentioned effects of DHL. Thus, DHL inhibits the malignancy of HepG2 human hepatocellular carcinoma cells via down-regulation of PI3K/AKT signaling pathway.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Bull Exp Biol Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Bull Exp Biol Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China